These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34915691)

  • 1. Primary benign back pain: supplementation with Pycnogenol®.
    Cox D; Belcaro G; Cesarone MR; Cotellese R; Dugall M; Feragalli B; Hosoi M; Corsi M; Luzzi R
    Panminerva Med; 2021 Dec; 63(4):472-477. PubMed ID: 34915691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome: prevention with Pycnogenol® and improvement of the venoarteriolar response.
    Belcaro G; Rohdewald P; Cesarone MR; Scipione C; Scipione V; Cornelli U; Luzzi R; Cotellese R; Dugall M; Hosoi M; Corsi M; Feragalli B
    Panminerva Med; 2022 Jun; 64(2):253-258. PubMed ID: 35815767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
    Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
    Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study.
    Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pycnogenol® supplementation alleviates symptoms of Parkinson's disease with mild cognitive impairment.
    Belcaro G; Cesarone MR; Hu S; Hosoi M; Ledda A; Feragalli B; Saggino A; Cotellese R
    J Neurosurg Sci; 2022 Aug; 66(4):371-377. PubMed ID: 36153882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
    Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
    Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pycnogenol® supplementation in minimal cognitive dysfunction.
    Hosoi M; Belcaro G; Saggino A; Luzzi R; Dugall M; Feragalli B
    J Neurosurg Sci; 2018 Jun; 62(3):279-284. PubMed ID: 29754480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xerostomia: prevention with Pycnogenol® supplementation: a pilot study.
    Belcaro G; Cesarone MR; Cornelli U; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Hosoi M; Maione C; Cotellese R; Cesinaro Di Rocco P
    Minerva Stomatol; 2019 Dec; 68(6):303-307. PubMed ID: 32052619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry.
    Ledda A; Cornelli U; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hu S; Corsi M
    Panminerva Med; 2020 Mar; 62(1):13-18. PubMed ID: 32199407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.
    Hu S; Hosoi M; Belcaro G; Dugall M; Feragalli B; Cotellese R; Luzzi R
    Minerva Cardioangiol; 2019 Oct; 67(5):392-398. PubMed ID: 31637898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostial and cartilage morphology in knee osteoarthritis: beneficial effects of supplementation with Pycnogenol® + Centellicum®.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Hosoi M; Hu S; Ledda A; Feragalli B; Cotellese R; Cox D
    Minerva Surg; 2024 Feb; 79(1):40-47. PubMed ID: 38381030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pycnogenol® supplementation to relieve symptoms after hemorrhoidectomy.
    Belcaro G; Cotellese R; Corsi M; Cesarone MR; Scipione C; Scipione V; Cornelli U; Ippolito E; Dugall M; Hosoi M; Feragalli B
    Minerva Surg; 2024 Jun; 79(3):309-314. PubMed ID: 38847768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
    Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementary management of symptomatic hand osteoarthritis with Pycnogenol®.
    Cesarone MR; Belcaro G; Cox D; Scipione V; Scipione C; Dugall M; Hosoi M; Feragalli B; Hu S; Coppazuccari F; Cotellese R
    Minerva Surg; 2024 Oct; 79(5):539-544. PubMed ID: 38980278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
    Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U
    J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
    Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
    Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xerostomia and prevention of dryness with a Pycnogenol® mouth spray: a pilot study.
    Cesarone MR; Belcaro G; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Cotellese R
    Minerva Gastroenterol (Torino); 2024 Mar; 70(1):36-41. PubMed ID: 37162467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.